Your browser doesn't support javascript.
loading
Incidence, Risk Factors, and Effect on Allograft Survival of Glomerulonephritis Post-transplantation in a United Kingdom Population: Cohort Study.
Aguiar, Rute; Bourmpaki, Elli; Bunce, Catey; Coker, Bola; Delaney, Florence; de Jongh, Leonardo; Oliveira, Giovani; Weir, Alistair; Higgins, Finola; Spiridou, Anastasia; Hasan, Syed; Smith, Jonathan; Mulla, Abdulrahim; Glampson, Ben; Mercuri, Luca; Montero, Rosa; Hernandez-Fuentes, Maria; Roufosse, Candice A; Simmonds, Naomi; Clatworthy, Menna; McLean, Adam; Ploeg, Rutger; Davies, Jim; Várnai, Kinga Anna; Woods, Kerrie; Lord, Graham; Pruthi, Rishi; Breen, Cormac; Chowdhury, Paramit.
Afiliação
  • Aguiar R; Department of Transplantation and Renal Medicine, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
  • Bourmpaki E; School of Population Health and Environmental Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
  • Bunce C; School of Population Health and Environmental Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.
  • Coker B; National Institute for Health and Care Research (NIHR) Biomedical Research Centre, Guy's & St Thomas' National Health Service (NHS) Foundation Trust and King's College London, London, United Kingdom.
  • Delaney F; National Institute for Health and Care Research (NIHR) Biomedical Research Centre, Guy's & St Thomas' National Health Service (NHS) Foundation Trust and King's College London, London, United Kingdom.
  • de Jongh L; National Institute for Health and Care Research (NIHR) Biomedical Research Centre, Guy's & St Thomas' National Health Service (NHS) Foundation Trust and King's College London, London, United Kingdom.
  • Oliveira G; National Institute for Health and Care Research (NIHR) Biomedical Research Centre, Guy's & St Thomas' National Health Service (NHS) Foundation Trust and King's College London, London, United Kingdom.
  • Weir A; National Institute for Health and Care Research (NIHR) Biomedical Research Centre, Guy's & St Thomas' National Health Service (NHS) Foundation Trust and King's College London, London, United Kingdom.
  • Higgins F; National Institute for Health and Care Research (NIHR) Biomedical Research Centre, Guy's & St Thomas' National Health Service (NHS) Foundation Trust and King's College London, London, United Kingdom.
  • Spiridou A; Data Research, Innovation and Virtual Environments Unit (DRIVE), Great Ormond Street Hospital for Children National Health Service (NHS) Foundation Trust, London, United Kingdom.
  • Hasan S; National Institute for Health and Care Research (NIHR) Biomedical Research Centre, Guy's & St Thomas' National Health Service (NHS) Foundation Trust and King's College London, London, United Kingdom.
  • Smith J; National Institute for Health and Care Research (NIHR) Biomedical Research Centre, Guy's & St Thomas' National Health Service (NHS) Foundation Trust and King's College London, London, United Kingdom.
  • Mulla A; National Institute for Health and Care Research (NIHR) Imperial Biomedical Research Centre, Imperial College London and Imperial College Healthcare National Health Service (NHS) Trust, Hammersmith Hospital, London, United Kingdom.
  • Glampson B; Research Informatics Team, Imperial College Healthcare National Health Service (NHS) Trust, London, United Kingdom.
  • Mercuri L; National Institute for Health and Care Research (NIHR) Imperial Biomedical Research Centre, Imperial College London and Imperial College Healthcare National Health Service (NHS) Trust, Hammersmith Hospital, London, United Kingdom.
  • Montero R; National Institute for Health and Care Research (NIHR) Biomedical Research Centre, Guy's & St Thomas' National Health Service (NHS) Foundation Trust and King's College London, London, United Kingdom.
  • Hernandez-Fuentes M; Tissue Remodelling Research at UCB, Slough, United Kingdom.
  • Roufosse CA; Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.
  • Simmonds N; Department of Immunology and Inflammation, Imperial College London, London, United Kingdom.
  • Clatworthy M; Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
  • McLean A; Renal Section, Department of Medicine, Hammersmith Hospital Campus, Imperial College London, London, United Kingdom.
  • Ploeg R; Nuffield Department of Surgical Sciences, Oxford Biomedical Research Centre, University of Oxford, Oxford, United Kingdom.
  • Davies J; National Institute for Health and Care Research (NIHR) Oxford Biomedical Research Centre, Big Data Institute, University of Oxford, Oxford, Oxfordshire, United Kingdom.
  • Várnai KA; Department of Computer Science, University of Oxford, Oxford, Oxfordshire, United Kingdom.
  • Woods K; National Institute for Health and Care Research (NIHR) Oxford Biomedical Research Centre, Big Data Institute, University of Oxford, Oxford, Oxfordshire, United Kingdom.
  • Lord G; Oxford University Hospitals National Health Service (NHS) Foundation Trust, Oxford, Oxfordshire, United Kingdom.
  • Pruthi R; National Institute for Health and Care Research (NIHR) Oxford Biomedical Research Centre, Big Data Institute, University of Oxford, Oxford, Oxfordshire, United Kingdom.
  • Breen C; Oxford University Hospitals National Health Service (NHS) Foundation Trust, Oxford, Oxfordshire, United Kingdom.
  • Chowdhury P; Faculty of Biology Medicine and Health, University of Manchester, Manchester, United Kingdom.
Front Nephrol ; 2: 923813, 2022.
Article em En | MEDLINE | ID: mdl-37675026
ABSTRACT

Background:

Post-transplant glomerulonephritis (PTGN) has been associated with inferior long-term allograft survival, and its incidence varies widely in the literature.

Methods:

This is a cohort study of 7,623 patients transplanted between 2005 and 2016 at four major transplant UK centres. The diagnosis of glomerulonephritis (GN) in the allograft was extracted from histology reports aided by the use of text-mining software. The incidence of the four most common GN post-transplantation was calculated, and the risk factors for disease and allograft outcomes were analyzed.

Results:

In total, 214 patients (2.8%) presented with PTGN. IgA nephropathy (IgAN), focal segmental glomerulosclerosis (FSGS), membranous nephropathy (MN), and membranoproliferative/mesangiocapillary GN (MPGN/MCGN) were the four most common forms of post-transplant GN. Living donation, HLA DR match, mixed race, and other ethnic minority groups were associated with an increased risk of developing a PTGN. Patients with PTGN showed a similar allograft survival to those without in the first 8 years of post-transplantation, but the results suggest that they do less well after that timepoint. IgAN was associated with the best allograft survival and FSGS with the worst allograft survival.

Conclusions:

PTGN has an important impact on long-term allograft survival. Significant challenges can be encountered when attempting to analyze large-scale data involving unstructured or complex data points, and the use of computational analysis can assist.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido